The dynamic nature of the K-Ras/calmodulin complex can be altered by oncogenic mutations

被引:11
|
作者
Abdelkarim, Hazem [1 ]
Leschinsky, Nicholas [1 ]
Jang, Hyunbum [2 ]
Banerjee, Avik [3 ]
Nussinov, Ruth [2 ,4 ]
Gaponenko, Vadim [1 ]
机构
[1] Univ Iinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA
[2] Natl Canc Inst, Frederick Natl Lab Canc Res, Computat Struct Biol Sect, Lab Canc Immunometabolism, Frederick, MD 21702 USA
[3] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Athens, GA 30602 USA
[4] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel
基金
美国国家卫生研究院;
关键词
SMALL GTPASE K-RAS4B; MEMBRANE-BINDING; HYPERVARIABLE REGION; RAS; CALMODULIN; KRAS; PHOSPHORYLATION; PROTEIN; DOMAIN; IDENTIFICATION;
D O I
10.1016/j.sbi.2021.06.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncogenic mutant K-Ras promotes cancer cell proliferation, migration, invasion, and survival by assembling signaling complexes. To date, the functional and structural roles of K-Ras mutations within these complexes are incompletely understood despite their mechanistic and therapeutic significance. Here, we review recent advances in understanding specific binding between K-Ras and the calcium sensor calmodulin. This interaction positively and negatively regulates diverse functions of K-Ras in cancer, suggesting flexibility in K-Ras/calmodulin complex formation. Also, structural data suggest that oncogenic K-Ras likely samples several conformational states, influencing its distinct assemblies with calmodulin and with other proteins. Understanding how K-Ras interacts with calmodulin and with other partners is essential to discovering novel inhibitors of K-Ras in cancer.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [41] Frequent K-ras mutations in small bowel adenocarcinomas
    Sutter, T
    Arber, N
    Moss, SF
    Findling, RI
    Neugut, AI
    Weinstein, IB
    Holt, PR
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (01) : 115 - 118
  • [42] K-ras and rho A mutations in malignant pleural effusion
    Nakamoto, M
    Teramoto, H
    Matsumoto, S
    Igishi, T
    Shimizu, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (05) : 971 - 976
  • [43] Identification of K-ras mutations in pancreatic juice - Reply
    Berthelemy, P
    Bouisson, M
    Pradayrol, L
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) : 1014 - 1015
  • [44] The Role of K-ras Mutations in Pancreatic Neuroendocrine Tumors
    Gilliland, K.
    Dong, H. J.
    Hochwald, S.
    Liu, C.
    LABORATORY INVESTIGATION, 2010, 90 : 355A - 356A
  • [45] APC and K-ras mutations in colorectal tumorigenesis.
    Umetani, N
    Masaki, T
    Sasaki, S
    Matsuda, K
    Muto, T
    GASTROENTEROLOGY, 1998, 114 (04) : A694 - A695
  • [46] Detection of K-ras mutations in resected primary leiomyosarcoma
    Hill, MA
    Gong, GN
    Casey, TJ
    Menon, AG
    Mera, R
    Gillespie, AT
    Giardina, JF
    Levine, EA
    Hunt, JD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (12) : 1095 - 1100
  • [47] HIGH-INCIDENCE OF K-RAS MUTATIONS IN RETINOBLASTOMA
    EMANUEL, J
    GRANVILLE, C
    HOWARD, R
    COSTA, J
    LABORATORY INVESTIGATION, 1995, 72 (01) : A137 - A137
  • [48] K-ras mutations in incident sporadic colorectal adenomas
    Barry, ELR
    Baron, JA
    Grau, MV
    Wallace, K
    Haile, RW
    CANCER, 2006, 106 (05) : 1036 - 1040
  • [49] K-RAS MUTATIONS IN MALE BREAST-CANCER
    SCHROER, KR
    FORTIER, CM
    WOLMAN, SR
    DAWSON, PJ
    LABORATORY INVESTIGATION, 1993, 68 (01) : A19 - A19
  • [50] K-ras Mutations in the Plasma of Colorectal Cancer Patients
    Shen, Yong-qi
    Ye, Yun-bin
    Zheng, Xiong-wei
    Li, Chao
    Chen, Qiang
    LABMEDICINE, 2010, 41 (03): : 156 - 158